Researchers have discovered a crucial early biomarker for the prediction of age-linked diseases – a study review by BIOMEDICA CRO team
Scientists from the University of Nottingham have discovered that the novel insulin-like peptide hormone, called INSL3, is consistent over long periods and is an important early biomarker for predicting age-linked disease.
The team analyzed blood samples from 3,000 men from 8 regional centers in north, south, east, and west of Europe, including the UK, with two samples taken four years apart. The results show that the level of INSL3 in blood correlates with a range of age-related illnesses, such as bone weakness, sexual dysfunction, diabetes, and cardiovascular disease.
“Now we know the important role this hormone plays in predicting disease and how it varies amongst men we are turning our attention to finding out what factors have the most influence on the level of INSL3 in the blood. Preliminary work suggests early life nutrition may play a role, but many other factors such as genetics or exposure to some environmental endocrine disruptors may play a part”, said Richard Ivell, Professor, University of Nottingham.
Please find more information on the University of Nottingham website, news, “Hormone discovery could predict long term health of men”.
Biospecimen company BIOMEDICA CRO – human biological samples and clinical data collection for research
BIOMEDICA CRO is a global partner in prospective and retrospective collections of the numerous human biospecimen types and associated clinical data.
We manage our network of 50+ direct contracts with hospitals and are always ready to make a new one if necessary. Our team can support your scientists in a broad range of oncological conditions and therapeutic diseases, which are included but not limited to the following list:
• Oncology (Breast, CRC, Kidney, Gastric cancers, Melanoma, etc.);
• Cardiology;
• Dermatology;
• Gastroenterology;
• Hematology;
• Gynecology and Urology;
• Endocrinology;
• Infections (including COVID-19);
• Traumatology, and many others.
In addition to human biospecimens, we can obtain precise clinical data, laboratory test results and other valuable information for each case.
BIOMEDICA CRO team is proud to participate in preclinical trials, in-vitro diagnostics and biomarkers discovery. We will be happy to cooperate once you need an additional supplier of biospecimens for your research.
Please email us to start our collaboration: office@biomedica-cro.com / LinkedIn.
